National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Cost-effectiveness of Regadenoson (Rapiscan®)

Rapid Review

Commenced Completed Outcome
19/09/2011 02/11/2011 Full Pharmacoeconomic Evaluation not Recommended.